1. Maron BJ. Hypertrophic cardiomyopathy. Lancet. 1997. 350:127–133.
2. Jeong JW. Hypertrophic cardiomyopathy. Korean Circ J. 2002. 32:7–14.
3. Tanaka M, Fujiwara H, Onodera T, Wu DJ, Hamashima Y, Kawai C. Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy. Br Heart J. 1986. 55:575–581.
4. Lopez B, Gonzalez A, Varo N, Laviades C, Querejeta R, Diez J. Biochemical assessment of myocardial fibrosis in hypertensive heart disease. Hypertension. 2001. 38:1222–1226.
5. Diez J, Laviades C, Mayor G, Gil MJ, Monreal I. Increased serum concentrations of procollagen peptides in essential hypertension: relation to cardiac alterations. Circulation. 1995. 91:1450–1456.
6. Lombardi R, Betocchi S, Losi MA, et al. Myocardial collagen turnover in hypertrophic cardiomyopathy. Circulation. 2003. 108:1455–1460.
7. Fassbach M, Schwartzkopff B. Elevated serum markers for collagen synthesis in patients with hypertrophic cardiomyopathy and diastolic dysfunction. Z Kardiol. 2005. 94:328–335.
8. Martos R, Baugh J, Ledwidge M, et al. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation. 2007. 115:888–895.
9. Diez J, Laviades C, Monreal I, Gil MJ, Panizo A, Pardo J. Toward the biochemical assessment of myocardial fibrosis in hypertensive patients. Am J Cardiol. 1995. 76:14D–17D.
10. Ihm SH, Youn HJ, Kim SR, et al. Relation between serum carboxy-terminal propeptide of type 1 procollagen (PIP), a marker of myocardial fibrosis, and left ventricular diastolic function in patients with early type 2 diabetes mellitus. Korean Circ J. 2005. 5:500–506.
11. Briguori C, Betocchi S, Romano M, et al. Exercise capacity in hypertrophic cardiomyopathy depends on left ventricular diastolic function. Am J Cardiol. 1999. 84:309–315.
12. Lele SS, Thomson HL, Seo H, Belenkie I, McKenna WJ, Frenneaux MP. Exercise capacity in hypertrophic cardiomyopathy: role of stroke volume limitation, heart rate, and diastolic filling characteristics. Circulation. 1995. 92:2886–2894.
13. Ha JW, Ahn JA, Kim JM, et al. Abnormal longitudinal myocardial functional reserve assessed by exercise tissue Doppler echocardiography in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2006. 19:1314–1319.
14. Choi EY, Ha JW, Rim SJ, et al. Incremental value of left ventricular diastolic function reserve index for predicting exercise capacity in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2008. 21:487–492.
15. Quinones MA, Waggoner AD, Reduto LA, et al. A new, simplified and accurate method for determining ejection fraction with two-dimentional echocardiography. Circulation. 1981. 64:744–753.
16. Oh JK, Seward JB, Tajik AJ. The Echo Manual. 1999. 2nd ed. Philadelphia: Lippincott Williams & Wilkins.
17. Ha JW, Lee CH, Park S, et al. Gender-related difference in left ventricular diastolic elastance during exercise in patients with diabetes mellitus. Circ J. 2008. 72:1443–1448.
18. Maron BJ, Bonow RO, Cannon RO 3rd, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med. 1987. 316:780–789.
19. Burlew BS, Weber KT. Cardiac fibrosis as a cause of diastolic dysfunction. Herz. 2002. 27:92–98.
20. Shirani J, Pick R, Roberts WC, Maron BJ. Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol. 2000. 35:36–44.